From: Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia
Parameters
HR
95%CI
P value
Hb < 100 g/L vs ≥100 g/L
2.42
1.40–4.19
0.002
IMCs presence vs absence
2.08
1.25–3.46
0.005
ASXL1 mut vs wt
1.99
1.20–3.28
0.007